TRACY ROBERTS: Open Payments
NPI 1396369138 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$932 in 24 payments from 12 companies in 2025. Trend: 2023 $730 · 2024 $629 · 2025 $932
Food & beverage: $932
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $404 |
| Neurocrine BioSciences, Inc. | 5 | $145 |
| Stryker Corporation | 2 | $66 |
| Novartis Pharmaceuticals Corporation | 2 | $57 |
| Teva Pharmaceuticals USA, Inc. | 2 | $55 |
| Exact Sciences Corporation | 2 | $55 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Philips North America LLC | 1 | $23 |
| ABBVIE INC. | 1 | $22 |
Products named: INGREZZA, REPATHA, MAKO, LEQVIO, AUSTEDO XR, Cologuard Collection Kit, FARXIGA, REXULTI.
Industry payments across ID — which companies pay providers there.
